Posts by Emily Nelson

ABF scientist Héctor García Martín is leading research that merges AI, mathematical modeling, and robotics with synthetic biology.

The Agile BioFoundry and seqWell are partnering to develop cost-effective, high-throughput workflows to accelerate strain engineering for biomanufacturing.

ABF and Kiverdi developed a set of genetic tools to improve the genetic engineering efficiency of a chemoautotrophic bacterium, advancing it as a microbial host that can directly convert carbon dioxide into valuable products. 

The ABF and UC Berkeley have demonstrated a high-throughput platform that leverages polyketide synthase enzymes to produce commodity chemicals and precursors to novel materials. 

Join us on April 10 at a workshop led by early-career Agile BioFoundry researchers to learn more about the Agile BioFoundry, what it’s like to work in synthetic biology/biomanufacturing, and career advancement opportunities.

The approach can generate the building blocks needed to develop synthetic genetic tools for algae biomanufacturing.

Our FY17-FY22 Impact Report outlines the Agile BioFoundry's activities and achievements for its first six years of operation.

Hear technical insights from ABF experts on biomanufacturing technologies that accelerate bioproduct R&D.

The process successfully scaled up by ABF and ABPDU produces a precursor to acrylic acid, widely used across the consumer product industry.

The project aims to enable the full-scale adoption of biofoundry applications in society, leveraging the expertise of successful biofoundries.